Product Information

TROSPIUM CHLORIDE ER 60 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $1.6097 per EA under NDC 00591363630. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Oct 12, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TROSPIUM CHLORIDE ER 60 MG CAP

Trospium Chloride
$1.6097per EA

Strength

60 mg/1

NDC

00591363630

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TROSPIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA091289

FDA Approved

10/12/2012

TE Code

AB

On Market Since

10/12/2012

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 67.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6097 per EA
All-time high$5.4731 (Sep 10, 2014)
All-time low$1.5910 (Nov 20, 2024)
52-week high$2.0448
52-week low$1.6097
Median price$4.0887
Average price$3.6854
Largest weekly change+44.7% (Aug 21, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.0%

3M

-8.6%

6M

-21.3%

1Y

-14.5%

3Y

-29.7%

5Y

-48.1%

All

-67.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TROSPIUM CHLORIDE ER 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for TROSPIUM CHLORIDE ER 60 MG CAP, manufactured by Actavis Pharma, Inc., is $1.6097 per EA (NDC 00591363630), effective Nov 11, 2026.

How has the price of TROSPIUM CHLORIDE ER 60 MG CAP changed over time?

Over the history we have for it, the NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has declined 67.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TROSPIUM CHLORIDE ER 60 MG CAP?

Since Nov 28, 2013, the NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has ranged from a low of $1.5910 (Nov 20, 2024) to a high of $5.4731 (Sep 10, 2014), with a median of $4.0887 per EA.

Are there cheaper alternatives to TROSPIUM CHLORIDE ER 60 MG CAP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TROSPIUM CHLORIDE ER 60 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TROSPIUM CHLORIDE ER 60 MG CAP?

TROSPIUM CHLORIDE ER 60 MG CAP (NDC 00591363630) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.